Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Sun Pharma acquires Biosintez
Asia
India-based drugs company Sun Pharma has agreed to acquire Russia-based pharmaceutical business Biosintez.   24 November 2016
IP and investment: put your money where your mouth is
Europe
Intellectual property in the life sciences arena can be an attractive investment target, but a long process of evaluation must take place first, cautions Dimitar Georgiev, founder and CEO of Paralax Life Sciences.   24 November 2016
Benin accepts TRIPS protocol on affordable medicines
Africa
Benin yesterday accepted the 2005 protocol amending the World Trade Organization’s (WTO) agreement on TRIPS, a protocol intended to ease poorer WTO members’ access to affordable medicines.   24 November 2016
Americas
The International Trademark Association (INTA) has filed an amicus brief asking the US Supreme Court to review a decision in a case between Belmora and Bayer centring on pain relief drug Flanax.   23 November 2016
Americas
California’s biopharmaceutical and medical device employment rate grew by 7% between 2011 and 2015, a recent report by the California Life Sciences Association (CLSA) and PwC US has revealed.   23 November 2016
Americas
Thermo Fisher Scientific sued US-based instrumentation company DeNovix yesterday for allegedly infringing two patents covering Thermo Fisher’s NanoDrop micro-volume spectrophotometers.   22 November 2016
Americas
Canada-based oral drug company IntelGenx has secured a licence from Eli Lilly to a patent covering tadalafil.   22 November 2016
Americas
McGuireWoods has promoted a partner in its Raleigh, North Carolina office, effective from January 1, 2017.   22 November 2016
Americas
Canada-based pharmaceutical corporation Apotex has filed a complaint for declaratory judgment of non-infringement against medical company Alcon in a patent case over an ophthalmic solution product.   21 November 2016
Americas
Biotech company United Therapeutics Corporation has filed a complaint against US-based Par Pharmaceutical for infringement of patents covering Remodulin.   21 November 2016